Previous 10 | Next 10 |
YOKNEAM, Israel, May 6, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced financial results for its first quarter ended March 31, 2020 . First Quarter 2020 Highlights: Quarterly revenue of ...
Right now, much of humanity is hunkered down, hiding from the world and that ugly COVID-19 bug. We're staying indoors, in our sweatpants, staring at video screens all day. We're shopping virtually, we're working virtually, and we're going to the doctor virtually. And when work is over, we're pla...
Soliton ( SOLY ) looks like an easy short. The pre-revenue aesthetics company is trying to commercialize its technology, but a potential recession should depress mid-term demand. That issue adds to an existing cash burn problem; Soliton will need to raise capital, likely before year-end. The...
YOKNEAM, Israel, April 7, 2020 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD ), a leading global provider of innovative medical technologies, announced today that it expects to release its results for the first quarter 2020 before the Nasdaq market opens on Wednesday, May 6, 2020 . Mr. ...
YOKNEAM, Israel , March 23, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today provided an update regarding its business activities in light of the ongoing global health situation caused by the COVID-19. As of to...
ZAGG (NASDAQ: ZAGG ) -44% after ending strategic review with no deal and Q4 earnings. More news on: ZAGG Inc, Sasol Limited, Party City Holdco Inc., Stocks on the move, , Read more ...
LAKE FOREST, California , Feb. 24, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD ) ("InMode"), a leading global provider of innovative medical technologies, has received Health Canada certification for Evoke, a breakthrough aesthetic solution for treating wrinkles and rhytids. ...
Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q4 2019 Earnings Call Feb 18, 2020 , 9:00 a.m. ET Operator Continue reading
InMode Ltd. (INMD) Q4 2019 Earnings Conference Call February 18, 2020 09:00 AM ET Company Participants Miri Segal - MS, IR Moshe Mizrahy - Chief Executive Officer, Chairman Dr. Michael Kreindel - Co-founder, CTO Yair Malca - Chief Financial Officer Rafi Likerman - VP, Finance...
Bellerophon Therapeutics (NASDAQ: BLPH ) +67% on positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study of INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis. More news on: Bellerophon Therape...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...